Sientra, an early-stage producer of silicone gel breast implants, announced terms for its IPO on Monday. The Santa Barbara, CA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Sientra would command a fully diluted market value of $230 million.
Business
Sientra received FDA approval in 2012 for its silicone gel breast products that use proprietary branded TRUE texture.
Help employers find you! Check out all the jobs and post your resume.
